What Researchers Did
Researchers investigated the effectiveness of adjunctive hyperbaric oxygen therapy in two patients with rhinocerebral mucormycosis that had extended to brain abscesses.
What They Found
Both patients, who had rhinocerebral mucormycosis with cerebral extension, showed marked clinical improvement after receiving adjunctive hyperbaric oxygen therapy. Both individuals remained disease-free 21 months post-hospital discharge.
What This Means for Canadian Patients
For Canadian patients suffering from severe rhinocerebral mucormycosis with cerebral extension, adjunctive hyperbaric oxygen therapy could be a life-saving treatment option. This approach might offer improved outcomes in cases where standard therapies like surgical debridement and amphotericin B are insufficient.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A significant limitation of this study is its very small sample size of only two patients, which limits the generalizability of the findings.